Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xu Jie Liu"'
Publikováno v:
International Journal of Nanomedicine
Xu-Jie Liu, Liang Li, Xiu-Jun Liu, Yi Li, Chun-Yan Zhao, Rui-Qi Wang, Yong-Su Zhen Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China Abstract: Previous st
Autor:
Xiaoxia Li, Zebin Mao, Xu-Jie Liu, Peng Li, Shuo Han, Li Shen, Jia-Zhen Qin, Yinan Liu, Kaiyu Liu, Xiu-Xiu Liu, Limin Hao, Xiaoyan Zhang
Publikováno v:
International Journal of Cancer. 136:2524-2534
To study the mechanisms underlying the IL-6-promoted angiogenic microenvironment in EGFRvIII-positive glioblastoma, VEGF expression in EGFRvIII-positive/negative tumors was determined by optical molecular imaging. Next, the HUVEC tube formation assay
Publikováno v:
Applied Mechanics and Materials. :3777-3780
In this paper, we propose a fast algorithm based on Reweighted Alternating Direction Method of Multiplier (R-ADMM) for cooperative compressive wideband spectrum sensing. The R-ADMM alternately updates the recovered signal matrix, the Lagrangian multi
Autor:
Xu Jie Liu, Bin Yan
Publikováno v:
Applied Mechanics and Materials. :1070-1073
This paper was based on the frame structure model with fixed support, and put forward five kinds of condition caused by uneven settlement. ANSYS was used to analyze the stress characteristics of frame structure. Through the comparative analysis of fi
Publikováno v:
Oncology reports. 32(1)
To increase the antitumor efficacy, in the present study, we proposed several settings of matrix metalloproteinase (MMP)-2/9-oriented combinations that comprise the MMP-2/9-targeting fusion protein dFv-LDP and the MMP inhibitor doxycycline (DOX) in a
Autor:
Li Shen, Qihua He, Jin-Ming Zhang, Xu-Jie Liu, Peng Li, Shuo Han, Xiaoyan Zhang, Jia-Zhen Qin, Feng Yin, Xiu-Xiu Liu, Yinan Liu, Kaiyu Liu, Wen-Tao Wu, Si-Hai Ma, Wei-Hua Wu
Publikováno v:
CNS neurosciencetherapeutics. 19(7)
AIMS: To study the contribution of epidermal growth factor receptor variant III (EGFRvIII) to glioblastoma multiforme (GBM) stemness and gefitinib resistance. METHODS: CD133(+) and CD133(−) cells were separated from EGFRvIII (+) clinical specimens
Publikováno v:
International Journal of Nanomedicine; Jul2017, Vol. 12, p5255-5269, 15p
Autor:
YE QIN, XIU-JUN LIU, LIANG LI, XU-JIE LIU, YI LI, RUI-JUAN GAO, RONG-GUANG SHAO, YONG-SU ZHEN
Publikováno v:
Oncology Reports; 2014, Vol. 32 Issue 1, p121-130, 10p
Autor:
Yuquan Xie, Haozhu Chen, Ruizhen Chen, Xu-Jie Liu, Yingzhen Yang, Yunzeng Zou, Yeqing Xie, Xian Zhang, Junbo Ge, Yong Yu, Ping Chen
Publikováno v:
Virology. (1):78-84
IL-17-producing (Th17) and regulatory T (Treg) cells have been well established in the pathogenesis of many inflammatory diseases. To assess whether Th17 and Treg were altered in acute virus-induced myocarditis (AVMC) mice, we assessed Th17/Treg func